The earnings call for MDxHealth reflected strong revenue growth and operational performance, particularly in the tissue-based test segment, with the company maintaining a strong financial position. However, there was an increase in net loss due to non-cash adjustments, and growth in the liquid-based tests segment was less impressive. Overall, the company demonstrated significant positive trends, particularly in revenue and profitability outlooks.

Company Guidance

During the MDxHealth First Quarter 2025 earnings call, the company provided guidance underscoring a robust outlook, targeting 20% or greater revenue growth for 2025 and beyond. The quarter marked the 16th consecutive period of achieving this growth benchmark, with Q1 revenue increasing by 22% and tissue-based test volumes rising by 41%. The company reported Q1 total billable volumes of approximately 24,000 tests, including 12,600 tissue-based tests and nearly 12,000 liquid-based tests. These results contributed to a Q1 revenue of $24.3 million, up from $19.8 million in the previous year, and a gross profit of $15.5 million, resulting in a 63.8% gross margin. MDxHealth reiterated its revenue guidance for 2025 at $108 million to $110 million and projected achieving positive adjusted EBITDA in Q2 2025.

Strong Revenue Growth

MDxHealth reported a 22% increase in revenues for the first quarter of 2025, reaching $24.3 million compared to $19.8 million in the same quarter of 2024.

Sustained Revenue Growth Record

This quarter marks the 16th consecutive quarter of 20% or greater revenue growth for MDxHealth.

Improved Gross Profit and Margin

Gross profit for the quarter was $15.5 million, a 29% increase from the prior year period, with gross margins improving to 63.8% from 60.8%.

Significant Growth in Tissue-Based Tests

Tissue-based test volume grew 41% in Q1, with the Confirm mdx and GPS tests contributing significantly to this growth.

Positive Adjusted EBITDA Outlook

MDxHealth expects to achieve positive adjusted EBITDA in the second quarter of 2025.

Financial Stability

Cash and cash equivalents were $65.7 million as of March 31, 2025, with a pro forma cash balance of $37.7 million after a $28 million earn-out payment.

MDxHealth (MDXH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MDXH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 12, 2025	2025 (Q3)	-0.11 / -	-0.4	―	―	―
Aug 05, 2025	2025 (Q2)	-0.12 / -0.15	-0.42	64.29% (+0.27)	―
May 14, 2025	2025 (Q1)	-0.13 / -0.19	-0.31	38.71% (+0.12)	―
Feb 26, 2025	2024 (Q4)	-0.19 / -0.14	-0.39	64.10% (+0.25)	―
Nov 06, 2024	2024 (Q3)	-0.27 / -0.40	-0.4	0.00% (0.00)
Aug 21, 2024	2024 (Q2)	-0.28 / -0.42	-0.4	-5.00% (-0.02)	―
May 01, 2024	2024 (Q1)	-0.30 / -0.31	-0.5	38.00% (+0.19)	―
Mar 06, 2024	2023 (Q4)	-0.21 / -0.39	-1.06	63.21% (+0.67)	―
Nov 08, 2023	2023 (Q3)	-0.30 / -0.40	-0.5	20.00% (+0.10)	―
Aug 23, 2023	2023 (Q2)	-0.33 / -0.40	-0.665	39.85% (+0.27)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MDXH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$2.49	$2.75	+10.44%
May 14, 2025	$1.78	$1.90	+6.74%
Feb 26, 2025	$1.83	$1.86	+1.64%
Nov 06, 2024	$2.08	$2.09	+0.48%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does MDxHealth (MDXH) report earnings?

MDxHealth (MDXH) is schdueled to report earning on Nov 12, 2025, Before Open (Confirmed).

What is MDxHealth (MDXH) earnings time?

MDxHealth (MDXH) earnings time is at Nov 12, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MDXH EPS forecast?

MDXH EPS forecast for the fiscal quarter 2025 (Q3) is -0.11.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing